Brad Racette

Research output

Research output per year 1998 2002 2004 2005 2006 2007 2008 2010 2011 2012 2013 2014 2015 2017 2018 2020 2021 2022

• 135 Article
• 7 Letter
• 6 Review article
• 5 Chapter
• 3 More
  • 2 Comment/debate
  • 1 Editorial

Research output per year

Research output per year

Search results

• Article

  [¹⁸F]FDOPA PET and clinical features in Parkinsonism due to manganism

  Racette, B. A., Antenor, J. A., McGee-Minnich, L., Moerlein, S. M., Videen, T. O., Kotagal, V. & Perlmutter, J. S., Apr 2005, In: Movement Disorders. 20, 4, p. 492-496 5 p.

  Research output: Contribution to journal › Article › peer-review

  • fluorodopa F 18 100%
  • Manganese 73%
  • Parkinsonian Disorders 67%
  • Globus Pallidus 28%
  • Parkinson Disease 20%
  86 Scopus citations

• [¹⁸F]FDOPA PET as an endophenotype for Parkinson's disease linkage studies

  Racette, B. A., Good, L., Antenor, J. A., McGee-Minnich, L., Moerlein, S. M., Videen, T. O. & Perlmutter, J. S., Apr 5 2006, In: American Journal of Medical Genetics - Neuropsychiatric Genetics. 141 B, 3, p. 245-249 5 p.

  Research output: Contribution to journal › Article › peer-review

  • fluorodopa F 18 100%
  • Endophenotypes 81%
  • Positron-Emission Tomography 57%
  • Parkinson Disease 51%
  • Amish 39%
  13 Scopus citations

• [ ¹⁸ F]FDOPA positron emission tomography in manganese-exposed workers

  Criswell, S. R., Nielsen, S. S., Warden, M., Perlmutter, J. S., Moerlein, S. M., Flores, H. P., Huang, J., Sheppard, L., Seixas, N., Checkoway, H. & Racette, B. A., Jan 2018, In: NeuroToxicology. 64, p. 43-49 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Manganese 100%
  • Positron 97%
  • Positron-Emission Tomography 77%
  • Occupational Groups 59%
  • Welding 34%
  17 Scopus citations

• 11C]dihydrotetrabenazine Positron Emission Tomography in Manganese-Exposed Workers

  Criswell, S. R., Nielsen, S. S., Warden, M. N., Perlmutter, J. S., Moerlein, S. M., Sheppard, L., Lenox-Krug, J., Checkoway, H. & Racette, B. A., Oct 1 2020, In: Journal of occupational and environmental medicine. 62, 10, p. 788-794 7 p.

  Research output: Contribution to journal › Article › peer-review

  • dihydrotetrabenazine 100%
  • Manganese 68%
  • Positron-Emission Tomography 53%
  • Occupational Groups 40%
  • worker 35%
  3 Scopus citations

• Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study

  Karamohamed, S., Golbe, L. I., Mark, M. H., Lazzarini, A. M., Suchowersky, O., Labelle, N., Guttman, M., Currie, L. J., Wooten, G. F., Stacy, M., Saint-Hilaire, M., Feldman, R. G., Liu, J., Shoemaker, C. M., Wilk, J. B., DeStefano, A. L., Latourelle, J. C., Xu, G., Watts, R., Growdon, J., & 14 othersLew, M., Waters, C., Vieregge, P., Pramstaller, P. P., Klein, C., Racette, B. A., Perlmutter, J. S., Parsian, A., Singer, C., Montgomery, E., Baker, K., Gusella, J. F., Herbert, A. & Myers, R. H., Sep 2005, In: Movement Disorders. 20, 9, p. 1188-1191 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Parkinson Disease 100%
  • Genes 48%
  • Genetic Variation 28%
  • Neurodegenerative Diseases 25%
  16 Scopus citations

• A comparison of prediction approaches for identifying prodromal Parkinson disease

  Warden, M. N., Nielsen, S. S., Camacho-Soto, A., Garnett, R. & Racette, B. A., Aug 2021, In: PloS one. 16, 8 August, e0256592.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Parkinson Disease 100%
  • Forests 70%
  • Logistic Models 58%
  • Area Under Curve 48%
  • Medicare Part D 46%
  2 Scopus citations

• A fixed-dose randomized controlled trial of olanzapine for psychosis in Parkinson disease

  Black, K. J., Nichols, M. J., Hartlein, J. M., Eicken, M. G. A. & Racette, B. A., Jul 9 2013, In: F1000Research. 2, 2-150.v1.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Olanzapine 100%
  • Psychotic Disorders 60%
  • Parkinson Disease 54%
  • Randomized Controlled Trials 43%
  • Clozapine 40%
  21 Scopus citations

• A haplotype at the PARK3 locus influences onset age for Parkinson's disease: The GenePD study

  Karamohamed, S., DeStefano, A. L., Wilk, J. B., Shoemaker, C. M., Golbe, L. I., Mark, M. H., Lazzarini, A. M., Suchowersky, O., Labelle, N., Guttman, M., Currie, L. J., Wooten, G. F., Stacy, M., Saint-Hilaire, M., Feldman, R. G., Sullivan, K. M., Xu, G., Watts, R., Growdon, J., Lew, M., & 14 othersWaters, C., Vieregge, P., Pramstaller, P. P., Klein, C., Racette, B. A., Perlmutter, J. S., Parsian, A., Singer, C., Montgomery, E., Baker, K., Gusella, J. F., Fink, S. J., Myers, R. H. & Herbert, A., Dec 9 2003, In: Neurology. 61, 11, p. 1557-1561 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Age of Onset 100%
  • Haplotypes 99%
  • Parkinson Disease 88%
  • sepiapterin reductase 77%
  • Single Nucleotide Polymorphism 53%
  51 Scopus citations

• A multi-incident, old-order Amish family with PD

  Racette, B. A., Rundle, M., Wang, J. C., Goate, A., Saccone, N. L., Farrer, M., Lincoln, S., Hussey, J., Smemo, S., Lin, J., Suarez, B., Parsian, A. & Perlmutter, J. S., Feb 26 2002, In: Neurology. 58, 4, p. 568-574 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Amish 100%
  • Mutation 34%
  • Levodopa 34%
  • Pedigree 33%
  • Haplotypes 29%
  11 Scopus citations

• A pilot clinical trial of creatine and minocycline in early parkinson disease: 18-month results

  The NINDS NET-PD Investigators, 2008, In: Clinical Neuropharmacology. 31, 3, p. 141-150 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Minocycline 100%
  • Creatine 95%
  • Parkinson Disease 67%
  • Medical Futility 56%
  • Clinical Trials 52%
  143 Scopus citations

• A population-based study of Parkinsonism in an Amish community

  Racette, B. A., Good, L. M., Kissel, A. M., Criswell, S. R. & Perlmutter, J. S., Oct 2009, In: Neuroepidemiology. 33, 3, p. 225-230 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Amish 100%
  • Parkinsonian Disorders 67%
  • Parkinson Disease 51%
  • Population 24%
  • Mental Status and Dementia Tests 18%
  17 Scopus citations

• A predictive model to identify Parkinson disease from administrative claims data

  Nielsen, S. S., Warden, M. N., Camacho-Soto, A., Willis, A. W., Wright, B. A. & Racette, B. A., Oct 3 2017, In: Neurology. 89, 14, p. 1448-1456 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Parkinson Disease 100%
  • Area Under Curve 58%
  • Medicare 49%
  • Demography 46%
  • Confidence Intervals 28%
  24 Scopus citations

• A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease

  The NINDS NET-PD Investigators, 2006, In: Neurology. 66, 5, p. 664-671 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Medical Futility 100%
  • Minocycline 88%
  • Creatine 84%
  • Tocopherols 62%
  • Parkinson Disease 59%
  343 Scopus citations

• A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease

  Kieburtz, K., Ravina, B., Galpern, W. R., Tilley, B., Shannon, K., Tanner, C., Wooten, G. F., Hamill, R., Sage, J. I., Kosa, E., Watts, R. L., Stover, N. R., McMurray, R., Lew, M. F., Kawai, C., Coffey, D., LeBlanc, P., Carter, J., Brodsky, M., Andrews, P., & 103 othersSiderowf, A., Reichwein, S., Shulman, L., Weiner, W. J., Pabst, K., Jaglin, J., Hauser, R., McClain, T., Delgado, H., Suchowersky, O., Derwent, L., Rao, J., Cook, M., Aminoff, M. J., Christine, C., Roth, J., Leehey, M., Bainbridge, J., Ross, G. W., Terashita, S., Singer, C., Perez, M. A., Blenke, A., Racette, B., Deppen, P., Elble, R., Young, C., Stewart, T., Sethi, K., Dill, B., Taylor, J., Roberge, P., Dewey, R. B., Hayward, B., Jankovic, J., Hunter, C., Wooten, F., Keller, M. F., Jennings, D., Kelsey, T., Martin, W., McInnes, G., Wojcieszek, J., Belden, J., Albin, R., Wernette, K., Savitt, J., Dunlop, B., Pahwa, R., Lyons, K. E., Parsons, A., Fang, J., Shearon, D., Feigin, A., Cox, M. M., Adler, C., Lind, M., Scott, B., Field, J., Nance, M., Peterson, S., Burns, R. S., Marlor, L., Van Bodis-Wollner, I., Hayes, E., Schneider, J., Sendek, S., Gollomp, S., Vernon, G., LeWitt, P., DeAngelis, M., Simon, D., Paul, L., Gorell, J., Krstevska, S., Flewellen, M., McCarthy, S., Uitti, R., Turk, M., Bower, J., Torgrimson, S., Sabbagh, M., Obradov, Z., Juncos, J., Weeks, M. L. M., Fernandez, H., Brown, G., Elm, J., Guimaraes, P., Huang, P., Palesch, Y., Kamp, C., Shinaman, A., Fraser, D., Brocht, A., Bennett, S., Weaver, C., Baker, D., Olsen, B., Goetz, C., Miyasaki, J., Fagan, S. & Mauldin, P., Jan 2007, In: Neurology. 68, 1, p. 20-28 9 p.

  Research output: Contribution to journal › Article › peer-review

  • GPI 1485 100%
  • Medical Futility 61%
  • coenzyme Q10 57%
  • Parkinson Disease 36%
  • Randomized Controlled Trials 29%
  196 Scopus citations

• A rapid method for mass screening for parkinsonism

  Racette, B. A., Tabbal, S. D., Jennings, D., Good, L. M., Perlmutter, J. S. & Evanoff, B. A., May 2006, In: NeuroToxicology. 27, 3, p. 357-361 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Mass Screening 100%
  • Parkinsonian Disorders 85%
  • Disorder 66%
  • Sampling 64%
  • Mental Status and Dementia Tests 40%
  12 Scopus citations

• A Rapid Motor Task-Based Screening Tool for Parkinsonism in Community-Based Studies

  Dlamini, W. W., Nielsen, S., Ushe, M., Nelson, G. & Racette, B. A., May 13 2021, In: Frontiers in Neurology. 12, 653066.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Parkinsonian Disorders 100%
  • Mental Status and Dementia Tests 94%
  • Datasets 27%
  • Area Under Curve 22%
  • Neurologists 15%

• A rare sequence variant in intron 1 of thap1 is associated with primary dystonia

  Vemula, S. R., Xiao, J., Zhao, Y., Bastian, R. W., Perlmutter, J. S., Racette, B. A., Paniello, R. C., Wszolek, Z. K., Uitti, R. J., Van Gerpen, J. A., Hedera, P., Truong, D. D., Blitzer, A., Rudzinska, M., Momcilovic, D., Jinnah, H. A., Frei, K., Pfeiffer, R. F. & Ledoux, M. S., May 2014, In: Molecular Genetics and Genomic Medicine. 2, 3, p. 261-272 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Dystonic Disorders 100%
  • Introns 70%
  • Dystonia 12 26%
  • Protein Isoforms 23%
  • G2 Phase 16%
  17 Scopus citations

• A screening tool to detect clinical manganese neurotoxicity

  Racette, B. A., Gross, A., Criswell, S. R., Checkoway, H. & Searles Nielsen, S., Jan 2018, In: NeuroToxicology. 64, p. 12-18 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Neurotoxicity 100%
  • Manganese 95%
  • Mental Status and Dementia Tests 82%
  • Area Under the Curve 75%
  • Welding 54%
  5 Scopus citations

• Association of a variation in the promoter region of the brain-derived neurotrophic factor gene with familial Parkinson's disease

  Parsian, A., Sinha, R., Racette, B., Zhao, J. H. & Perlmutter, J. S., Jun 2004, In: Parkinsonism and Related Disorders. 10, 4, p. 213-219 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Brain-Derived Neurotrophic Factor 100%
  • Genetic Promoter Regions 91%
  • Parkinson Disease 79%
  • Genes 38%
  • Single Nucleotide Polymorphism 19%
  36 Scopus citations

• Association of variations in monoamine oxidases A and B with Parkinson's disease subgroups

  Parsian, A., Racette, B., Zhang, Z. H., Rundle, M. & Perlmutter, J. S., Mar 2004, In: Genomics. 83, 3, p. 454-460 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Monoamine Oxidase 100%
  • Parkinson Disease 71%
  • Genes 14%
  • Age of Onset 11%
  • Dinucleotide Repeats 9%
  21 Scopus citations

• Association of α-synuclein gene haplotypes with Parkinson's disease

  Parsian, A. J., Racette, B. A., Zhao, J. H., Sinha, R., Patra, B., Perlmutter, J. S. & Parsian, A., Aug 2007, In: Parkinsonism and Related Disorders. 13, 6, p. 343-347 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Synucleins 100%
  • Haplotypes 62%
  • Parkinson Disease 55%
  • Genes 26%
  • Gene Frequency 25%
  13 Scopus citations

• Basal ganglia intensity indices and diffusion weighted imaging in manganese-exposed welders

  Criswell, S. R., Perlmutter, J. S., Huang, J. L., Golchin, N., Flores, H. P., Hobson, A., Aschner, M., Erikson, K. M., Checkoway, H. & Racette, B. A., Jun 2012, In: Occupational and Environmental Medicine. 69, 6, p. 437-443 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Manganese 100%
  • Basal Ganglia 84%
  • Putamen 58%
  • Globus Pallidus 36%
  • Welding 14%
  81 Scopus citations

• BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study

  Karamohamed, S., Latourelle, J. C., Racette, B. A., Perlmutter, J. S., Wooten, G. F., Lew, M., Klein, C., Shill, H., Golbe, L. I., Mark, M. H., Guttman, M., Nicholson, G., Wilk, J. B., Saint-Hilaire, M., DeStefano, A. L., Prakash, R., Tobin, S., Williamson, J., Suchowersky, O., Labell, N., & 16 othersGrowdon, B. N. J., Singer, C., Watts, R., Goldwurm, S., Pezzoli, G., Baker, K. B., Giroux, M. L., Pramstaller, P. P., Burn, D. J., Chinnery, P., Sherman, S., Vieregge, P., Litvan, I., Gusella, J. F., Myers, R. H. & Parsian, A., Dec 2005, In: Neurology. 65, 11, p. 1823-1825 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Brain-Derived Neurotrophic Factor 100%
  • Age of Onset 89%
  • Parkinson Disease 79%
  • Substantia Nigra 25%
  • Dopaminergic Neurons 24%
  61 Scopus citations

• Blood manganese as an exposure biomarker: State of the evidence

  Baker, M. G., Simpson, C. D., Stover, B., Sheppard, L., Checkoway, H., Racette, B. A. & Seixas, N. S., Apr 1 2014, In: Journal of Occupational and Environmental Hygiene. 11, 4, p. 210-217 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Manganese 100%
  • air 65%
  • Biomarkers 54%
  • evidence 34%
  • Air 29%
  50 Scopus citations

• Botulinum toxin B reduces sialorrhea in parkinsonism

  Racette, B. A., Good, L., Sagitto, S. & Perlmuter, J. S., Sep 1 2003, In: Movement Disorders. 18, 9, p. 1059-1061 3 p.

  Research output: Contribution to journal › Article › peer-review

  • rimabotulinumtoxinB 100%
  • Sialorrhea 89%
  • Parkinsonian Disorders 69%
  • Salivation 28%
  • Parotid Gland 24%
  53 Scopus citations

• Botulinum toxin effects on gasatrocnemius strength and plantar pressure in diabetics with peripheral neuropathy and forefoot ulceration

  Hastings, M. K., Mueller, M. J., Sinacore, D. R., Strube, M. J., Crowner, B. E., Johnson, J. E. & Racette, B. R., May 2012, In: Foot and Ankle International. 33, 5, p. 363-370 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Type A Botulinum Toxins 100%
  • Botulinum Toxins 98%
  • Peripheral Nervous System Diseases 87%
  • Pressure 53%
  • Torque 45%
  6 Scopus citations

• Bright light exposure reduces TH-positive dopamine neurons: Implications of light pollution in Parkinson's disease epidemiology

  Romeo, S., Viaggi, C., Di Camillo, D., Willis, A. W., Lozzi, L., Rocchi, C., Capannolo, M., Aloisi, G., Vaglini, F., MacCarone, R., Caleo, M., Missale, C., Racette, B. A., Corsini, G. U. & Maggio, R., 2013, In: Scientific reports. 3, 1395.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Tyrosine 3-Monooxygenase 100%
  • Dopaminergic Neurons 95%
  • neuromelanin 88%
  • Parkinson Disease 76%
  • Epidemiology 71%
  30 Scopus citations

• Clinical features and comorbidity of mood fluctuations in Parkinson's disease

  Racette, B. A., Hartlein, J. M., Hershey, T., Mink, J. W., Perlmutter, J. S. & Black, K. J., Jan 1 2002, In: Journal of Neuropsychiatry and Clinical Neurosciences. 14, 4, p. 438-442 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Parkinson Disease 100%
  • Comorbidity 93%
  • Levodopa 44%
  • Age of Onset 37%
  • Psychotic Disorders 37%
  52 Scopus citations

• Clinical-genetic associations in the Prospective Huntington at Risk Observational Study (PHAROS) implications for clinical trials

  The Huntington Study Group PHAROS Investigators, Jan 2016, In: JAMA Neurology. 73, 1, p. 102-110 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cytosine 100%
  • Guanine 99%
  • Adenine 99%
  • Huntington Disease 81%
  • Observational Studies 65%
  31 Scopus citations

• Clinical presentation and self-reported patterns of pain and function in patients with plantar heel pain

  Klein, S. E., Dale, A. M., Hayes, M. H., Johnson, J. E., McCormick, J. J. & Racette, B. A., Sep 2012, In: Foot and Ankle International. 33, 9, p. 693-698 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Heel 100%
  • Pain 49%
  • Plantar Fasciitis 48%
  • Foot 27%
  • Ankle 20%
  27 Scopus citations

• Cognitive control dysfunction in workers exposed to manganese-containing welding fume

  Al-Lozi, A., Nielsen, S. S., Hershey, T., Birke, A., Checkoway, H., Criswell, S. R. & Racette, B. A., Feb 1 2017, In: American Journal of Industrial Medicine. 60, 2, p. 181-188 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Welding 100%
  • Manganese 88%
  • Cognitive Dysfunction 60%
  • Occupational Groups 52%
  • worker 46%
  15 Scopus citations

• Conjugal Parkinsonism and Parkinson disease: A case series with environmental risk factor analysis

  Willis, A. W., Sterling, C. & Racette, B. A., Mar 2010, In: Parkinsonism and Related Disorders. 16, 3, p. 163-166 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Heavy Metals 100%
  • Parkinsonian Disorders 92%
  • Environmental Exposure 91%
  • Statistical Factor Analysis 74%
  • Parkinson Disease 70%
  20 Scopus citations

• Convergence insufficiency in idiopathic Parkinson's disease responsive to levodopa

  Racette, B. A., Gokden, M., Tychsen, L. & Perlmutter, J. S., 1999, In: Strabismus. 7, 3, p. 169-174 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Ocular Motility Disorders 100%
  • Levodopa 80%
  • Parkinson Disease 60%
  • Diplopia 57%
  41 Scopus citations

• Depression and anxiety in a manganese-exposed community

  Racette, B. A., Nelson, G., Dlamini, W. W., Hershey, T., Prathibha, P., Turner, J. R., Checkoway, H., Sheppard, L. & Searles Nielsen, S., Jul 2021, In: NeuroToxicology. 85, p. 222-233 12 p.

  Research output: Contribution to journal › Article › peer-review

  • Manganese 100%
  • Anxiety 59%
  • Depression 54%
  • Equipment and Supplies 41%
  • Black 18%
  4 Scopus citations

• Design innovations and baseline findings in a long-term parkinson’s trial: The national institute of neurological disorders and stroke exploratory trials in parkinson’s disease long-term study-1

  The NINDS NET-PD Investigators, Oct 2012, In: Movement Disorders. 27, 12, p. 1513-1521 9 p.

  Research output: Contribution to journal › Article › peer-review

  • National Institute of Neurological Disorders and Stroke (U.S.) 100%
  • Parkinson Disease 56%
  • Creatine 49%
  • Medical Futility 23%
  • Placebos 17%
  53 Scopus citations

• Disparities in deep brain stimulation surgery among insured elders with Parkinson disease

  Willis, A. W., Schootman, M., Kung, N., Wang, X. Y., Perlmutter, J. S. & Racette, B. A., Jan 14 2014, In: Neurology. 82, 2, p. 163-171 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Deep Brain Stimulation 100%
  • Parkinson Disease 72%
  • Odds Ratio 19%
  • Medicare 19%
  • Confidence Intervals 18%
  65 Scopus citations

• DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease

  Lin, X., Cook, T. J., Zabetian, C. P., Leverenz, J. B., Peskind, E. R., Hu, S. C., Cain, K. C., Pan, C., Edgar, J. S., Goodlett, D. R., Racette, B. A., Checkoway, H., Montine, T. J., Shi, M. & Zhang, J., 2012, In: Scientific reports. 2, 954.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Parkinson Disease 100%
  • Protein Isoforms 96%
  • Biomarkers 77%
  • Synucleinopathies 33%
  • 4-hydroxy-2-nonenal 31%
  79 Scopus citations

• Dose-dependent progression of parkinsonism in manganese-exposed welders

  Racette, B. A., Nielsen, S. S., Criswell, S. R., Sheppard, L., Seixas, N., Warden, M. N. & Checkoway, H., Jan 24 2017, In: Neurology. 88, 4, p. 344-351 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Manganese 100%
  • Welding 97%
  • Parkinsonian Disorders 91%
  • Mental Status and Dementia Tests 37%
  • Upper Extremity 32%
  70 Scopus citations

• Dystonia in a patient with ring chromosome 21

  Hou, C. E., Schlaggar, B. L. & Racette, B. A., Dec 2003, In: Movement Disorders. 18, 12, p. 1547-1549 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Chromosome 21 ring 100%
  • Dystonic Disorders 69%
  • Torticollis 68%
  • Dystonia 59%
  • Karyotype 51%

• Effects of parkinsonism on health status in welding exposed workers

  Harris, R. C., Lundin, J. I., Criswell, S. R., Hobson, A., Swisher, L. M., Evanoff, B. A., Checkoway, H. & Racette, B. A., Nov 2011, In: Parkinsonism and Related Disorders. 17, 9, p. 672-676 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Welding 100%
  • Parkinsonian Disorders 80%
  • Health Status 63%
  • Occupational Groups 52%
  • Parkinson Disease 40%
  17 Scopus citations

• Efficacy and safety of a new bulk toxin of botulinum toxin in cervical dystonia: A blinded evaluation

  Racette, B. A., McGee-Minnich, L. & Perlmutter, J. S., Nov 1999, In: Clinical Neuropharmacology. 22, 6, p. 337-339 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Torticollis 100%
  • Type A Botulinum Toxins 90%
  • Botulinum Toxins 88%
  • Safety 43%
  • Deglutition Disorders 37%
  23 Scopus citations

• Efficacy and safety of onabotulinumtoxinA with standardized physiotherapy for the treatment of pediatric lower limb spasticity: A randomized, placebo-controlled, phase III clinical trial

  Dimitrova, R., Kim, H., Meilahn, J., Chambers, H. G., Racette, B. A., Bonikowski, M., Park, E. S., McCusker, E., Liu, C. & Brin, M. F., 2022, In: NeuroRehabilitation. 50, 1, p. 33-46 14 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Type A Botulinum Toxins 100%
  • Phase III Clinical Trials 99%
  • Lower Extremity 67%
  • Placebos 57%
  • Pediatrics 53%

• Environmental manganese exposure and cognitive control in a South African population

  Racette, B., Nelson, G., Dlamini, W. W., Hershey, T., Prathibha, P., Turner, J. R., Checkoway, H., Sheppard, L. & Searles Nielsen, S., Mar 2022, In: NeuroToxicology. 89, p. 31-40 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Manganese 100%
  • Environmental Exposure 90%
  • Confidence Intervals 41%
  • Population 32%
  • Black 24%
  2 Scopus citations

• Epidemiological studies of parkinsonism in welders

  Checkoway, H., Nielsen, S. S. & Racette, B. A., Jan 1 2015, In: Issues in Toxicology. 2015-January, 22, p. 513-523 11 p.

  Research output: Contribution to journal › Article › peer-review

• Epidemiology and neuropsychiatric manifestations of Young Onset Parkinson's Disease in the United States

  Willis, A. W., Schootman, M., Kung, N. & Racette, B. A., Feb 2013, In: Parkinsonism and Related Disorders. 19, 2, p. 202-206 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Parkinson Disease 100%
  • Epidemiology 93%
  • Medicare 41%
  • African Continental Ancestry Group 26%
  • Population 25%
  28 Scopus citations

• Estimation of particulate mass and manganese exposure levels among welders

  Hobson, A., Seixas, N., Sterling, D. & Racette, B. A., Jan 2011, In: Annals of Occupational Hygiene. 55, 1, p. 113-125 13 p.

  Research output: Contribution to journal › Article › peer-review

  • Welding 100%
  • Manganese 88%
  • determinants 15%
  • epidemiological studies 8%
  • Ventilation 8%
  43 Scopus citations

• Evaluation of a screening questionnaire for genetic studies of Parkinson's disease

  Racette, B. A., Rundle, M., Parsian, A. & Perlmutter, J. S., Oct 15 1999, In: American Journal of Medical Genetics - Neuropsychiatric Genetics. 88, 5, p. 539-543 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Genetic Testing 100%
  • Parkinson Disease 81%
  • Undiagnosed Diseases 49%
  • Parkinsonian Disorders 17%
  • Genetic Research 10%
  91 Scopus citations

• Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's disease

  Li, Y., Grupe, A., Rowland, C., Holmans, P., Segurado, R., Abraham, R., Jones, L., Catanese, J., Ross, D., Mayo, K., Martinez, M., Hollingworth, P., Goate, A., Cairns, N. J., Racette, B. A., Perlmutter, J. S., O'Donovan, M. C., Morris, J. C., Brayne, C., Rubinsztein, D. C., & 4 othersLovestone, S., Thal, L. J., Owen, M. J. & Williams, J., Mar 1 2008, In: Human molecular genetics. 17, 5, p. 759-767 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Parkinson Disease 100%
  • Alzheimer Disease 92%
  • Single Nucleotide Polymorphism 50%
  • Genes 48%
  • Odds Ratio 38%
  36 Scopus citations

• Ex vivo magnetic resonance imaging in South African manganese mine workers

  Criswell, S. R., Nelson, G., Gonzalez-Cuyar, L. F., Huang, J., Shimony, J. S., Checkoway, H., Simpson, C. D., Dills, R., Seixas, N. S. & Racette, B. A., Jul 1 2015, In: NeuroToxicology. 49, p. 8-14 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Miners 100%
  • Manganese 90%
  • Magnetic Resonance Imaging 50%
  • Basal Ganglia 28%
  • Putamen 23%
  12 Scopus citations

• Formulations of hormone therapy and risk of Parkinson's disease

  Lundin, J. I., Ton, T. G. N., Lacroix, A. Z., Longstreth, W. T., Franklin, G. M., Swanson, P. D., Smith-Weller, T., Racette, B. A. & Checkoway, H., Nov 1 2014, In: Movement Disorders. 29, 13, p. 1631-1636 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Parkinson Disease 100%
  • Hormones 84%
  • Conjugated (USP) Estrogens 81%
  • Progestins 65%
  • Estrogens 61%
  11 Scopus citations